Michelle Hamilton
Family · Pensacola, FLNPI 1154986677
Payments from drug & device makers
Across 353 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1K
- GSK$997
- AstraZeneca$861
- Jazz Pharmaceuticals Inc.$666
- Actelion Pharmaceuticals US, Inc.$435
- Sanofi$423
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,525100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 79 | $1,273 |
| GSK | 76 | $997 |
| AstraZeneca(2 entities) | 43 | $861 |
| Jazz Pharmaceuticals Inc. | 27 | $666 |
| Actelion Pharmaceuticals US, Inc. | 18 | $435 |
| Sanofi | 14 | $423 |
| Insmed, Inc. | 19 | $363 |
| Regeneron Healthcare Solutions, Inc. | 12 | $288 |
| Grifols USA, LLC | 10 | $210 |
| Verona Pharma, Inc. | 8 | $141 |
| Boston Scientific | 10 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Amgen | 3 | $73 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $64 |
| Bayer | 3 | $53 |
| Mylan Specialty L.p. | 2 | $50 |
| Abiomed | 2 | $49 |
| Chiesi USA, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Teleflex LLC | 1 | $31 |
| Inogen, Inc. | 1 | $26 |
| Vapotherm Inc | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| United Therapeutics Corporation | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Pulmonx Corporation | 1 | $14 |
| Philips North America LLC | 1 | $14 |
| AbbVie | 1 | $14 |
How this compares
$6,525 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 521 | $401,747 |
| OfevNintedanib Esylate | 25 | $331,916 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 206 | $168,789 |
| Fasenra PenBenralizumab | 17 | $112,018 |
| Breo ElliptaFluticasone/Vilanterol | 217 | $105,820 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 12 | $85,742 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 75 | $43,620 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 73 | $39,127 |
| Spiriva RespimatTiotropium Bromide | 41 | $28,755 |
| SymbicortBudesonide/Formoterol Fumarate | 66 | $19,862 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 447 | $12,170 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $10,855 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 82 | $9,612 |
| BreynaBudesonide/Formoterol Fumarate | 22 | $5,375 |
| Wixela InhubFluticasone Propion/Salmeterol | 21 | $2,362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $997 | $551,187813 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $1,273 | $399,797139 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $861 | $188,652272 claims |
| Grifols USA, LLCProlastin C | $210 | $85,74212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Pensacola
- Brittany PerezPensacola$130K
- Mary AanestadPensacola$54K
- Raymond HalsteadPensacola$50K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.